Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
451
datasets available to search
ShareScore release 0.9.0
Dataset results
451 results for “AMD”
A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD
ClinicalTrials.gov study NCT00469352. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT01024998. IPD Sharing: Not stated. Countries: 1. Publications: 1.
VITAL - Individualising Therapy for Neovascular AMD With Aflibercept
ClinicalTrials.gov study NCT02441816. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Transplantation of Autologous RPE Versus Translocation of Autologous RPE and Choroid in AMD
ClinicalTrials.gov study NCT00401713. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD
ClinicalTrials.gov study NCT04676854. IPD Sharing: NO. Countries: 6. Publications: 2.
EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00470678. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ADVM-022 Intravitreal Gene Therapy for Wet AMD
ClinicalTrials.gov study NCT03748784. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD
ClinicalTrials.gov study NCT00684853. IPD Sharing: Not stated. Countries: 1. Publications: 12.
Data from: Low incidence of choroidal neovascularization following subthreshold diode micropulse laser (SDM) in high-risk AMD
Open the record for dataset details and reuse information.
Data from: The Moorfields AMD database report 2 - fellow eye involvement with neovascular age-related macular degeneration
<p><b>Background/Aims:</b> Neovascular age-related macular degeneration (nAMD) is frequently bilateral, and previous reports on 'fellow eyes'' have assumed sequential treatment after a period of treatment of the first eye only. The aim of our study was to analyse baseline characteristics and visual acuity (VA) outcomes of fellow eye involvement with nAMD, specifically differentiating between sequential and non-sequential (due to macular scarring in the first eye) anti-vascular endothelial growth factor treatment and timelines for fellow eye involvement.</p> <p><b>Methods:</b> Retrospective, electronic medical record database study of the Moorfields AMD database of 6265 patients /120,286 single entries with data extracted between October 21, 2008 and August 9, 2018. The dataset for analysis consisted of 1180 sequential, 807 nonsequential, and 3410 unilateral eyes.</p> <p><b>Results: </b>Mean VA (Early Treatment Diabetic Retinopathy Study letters±SD) of sequentially treated fellow eyes at baseline was significantly higher (63±13), VA gain over two years lower (0.37±14), and proportion of eyes with good VA (≥70 letters) higher (46%) than the respective first eyes (baseline VA 54±16, VA gain at two years 5.6±15, percentage of eyes with good VA 39%). Non-sequential fellow eyes showed baseline characteristics and VA outcomes similar to first eyes. Fellow eye involvement rate was 32% at two years, and median time interval to fellow eye involvement was 71 (IQR 27-147) weeks.</p> <p><b>Conclusion:</b> This report shows sequentially treated nAMD fellow eyes have better baseline and final VA than non-sequentially treated eyes after 2 years of treatment. Sequentially treated eyes also had a greater proportion with good VA after 2 years.</p>
Supplementary information for "GROMACS on AMD GPU-Based HPC Platforms: Using SYCL for Performance and Portability"
<p>GROMACS inputs for the performance benchmarks in the manuscript.</p>
Dataset: GraniteShares 2x Long AMD Daily ETF (AMDL) Stock Performance
This dataset provides historical stock market performance data for specific companies. It enables users to analyze and understand the past trends and fluctuations in stock prices over time. This information can be utilized for various purposes such as investment analysis, financial research, and market trend forecasting.
SCHEDA HTA AMDS
<p>SCHEDA HTA AMDS</p>
Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal Pegcetacoplan (APL-2) for Patients With Wet AMD
ClinicalTrials.gov study NCT02461771. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Ranibizumab and Reduced Fluence PDT for AMD
ClinicalTrials.gov study NCT00527475. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)
ClinicalTrials.gov study NCT01722045. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Omega-3 Supplementation and Vitreal VEGF Levels in Wet-AMD
ClinicalTrials.gov study NCT01819415. IPD Sharing: NO. Countries: 1. Publications: 0.
Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD
ClinicalTrials.gov study NCT02684578. IPD Sharing: NO. Countries: 1. Publications: 0.
Cataract and AMD in a Trial of a Multivitamin and Cocoa Extract
ClinicalTrials.gov study NCT03205202. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00407719. IPD Sharing: Not stated. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.